Skip to content

Single Dose of Antenatal Corticosteroids for Pregnancies At Risk of Preterm Delivery (SNACS)

Premature Birth | Obstetric Labor, Premature | Pregnancy Complications | Preterm Birth | Complication of Prematurity

Antenatal corticosteroids (ACS) reduce the risks of neonatal death and morbidities in preterm infants, such as respiratory distress syndrome.

The standard of care for pregnant people at risk of preterm birth includes 2 doses of Celestone (for a total of 24 mg in Canada, or 22.8 mg in Australia) to accelerate fetal lung maturity.

The investigators plan to conduct a randomized controlled trial to determine whether half the usual dose (12 mg in Canada, or 11.4 mg in Australia) of Celestone is non-inferior to the standard double doses.

null

Participation Requirements

  • Sex:

    FEMALE
  • Eligible Ages:

    18 to 55

Participation Criteria

Inclusion Criteria:

1. Pregnant people, aged 18 to 55 years old, at risk of preterm birth with a singleton or twins between 22 weeks and 0 days and \<34 weeks and 6 days gestation who have received only a single dose of Celestone within 24 hours
2. Capable of giving informed, written consent.

Exclusion Criteria:

1. Contraindication to corticosteroids
2. Systemic corticosteroids for medical conditions during the pregnancy (e.g. lupus, severe asthma, Covid, etc).
3. Previous participation in this trial (in a previous pregnancy)
4. Known severe/life-threatening fetal or pregnant patient condition (e.g. fetal congenital/chromosomal abnormality)
5. Demise of one or more fetuses after 14 weeks and 0 days

Study Location

Alberta Health Services; University of Alberta
Alberta Health Services; University of Alberta
Edmonton, Alberta
Canada

Contact Study Team

Victoria General Hospital
Victoria General Hospital
Victoria, British Columbia
Canada

Contact Study Team

The Moncton Hospital, Horizon Health Network
The Moncton Hospital, Horizon Health Network
Moncton, New Brunswick
Canada

Contact Study Team

Queen's University, Kingston General Hospital Health Sciences Centre
Queen's University, Kingston General Hospital Health Sciences Centre
Kingston, Ontario
Canada

Contact Study Team

Sunnybrook Health Sciences Center
Sunnybrook Health Sciences Center
Toronto, Ontario
Canada

Contact Study Team

Université Laval, Centre de recherche du CHU de Québec
Université Laval, Centre de recherche du CHU de Québec
Québec City, Quebec
Canada

Contact Study Team

University of Calgary, Cumming School of Medicine
University of Calgary, Cumming School of Medicine
Calgary, Alberta
Canada

Contact Study Team

University of British Columbia; BC Women's Hospital
University of British Columbia; BC Women's Hospital
Vancouver, British Columbia
Canada

Contact Study Team

Dr. Everett Chalmers Regional Hospital
Dr. Everett Chalmers Regional Hospital
Fredericton, New Brunswick
Canada

Contact Study Team

McMaster University
McMaster University
Hamilton, Ontario
Canada

Contact Study Team

Mount Sinai Hospital
Mount Sinai Hospital
Toronto, Ontario
Canada

Contact Study Team

The Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal
The Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal
Montréal, Quebec
Canada

Contact Study Team

Royal Columbian Hospital
Royal Columbian Hospital
New Westminster, British Columbia
Canada

Contact Study Team

University of Manitoba, Health Sciences Centre
University of Manitoba, Health Sciences Centre
Winnipeg, Manitoba
Canada

Contact Study Team

Memorial University, Eastern Health
Memorial University, Eastern Health
St. John's, Newfoundland and Labrador
Canada

Contact Study Team

Western University; London Health Sciences Centre, Victoria Hospital
Western University; London Health Sciences Centre, Victoria Hospital
London, Ontario
Canada

Contact Study Team

McGill University, McGill University Health Center, Royal Victoria Hospital
McGill University, McGill University Health Center, Royal Victoria Hospital
Montréal, Quebec
Canada

Contact Study Team

(CIUSSS de l'Estrie-CHUS); Université de Sherbrooke
(CIUSSS de l'Estrie-CHUS); Université de Sherbrooke
Sherbrooke, Quebec
Canada

Contact Study Team

Fraser Health, University of British Columbia; Jim Pattison Outpatient Care and Surgery Centre
Fraser Health, University of British Columbia; Jim Pattison Outpatient Care and Surgery Centre
Surrey, British Columbia
Canada

Contact Study Team

University of Manitoba; St. Boniface General Hospital
University of Manitoba; St. Boniface General Hospital
Winnipeg, Manitoba
Canada

Contact Study Team

Dalhousie University; Izaak Walton Killam Health
Dalhousie University; Izaak Walton Killam Health
Halifax, Nova Scotia
Canada

Contact Study Team

University of Ottawa; The Ottawa Hospital
University of Ottawa; The Ottawa Hospital
Ottawa, Ontario
Canada

Contact Study Team

Sir Mortimer B. Davis Jewish General Hospital; McGill University
Sir Mortimer B. Davis Jewish General Hospital; McGill University
Montréal, Quebec
Canada

Contact Study Team

University of Saskatchewan, Regina General Hospital
University of Saskatchewan, Regina General Hospital
Saskatoon, Saskatchewan
Canada

Contact Study Team

Study Sponsored By
McMaster University
Participants Required
More Information
Study ID: NCT05114096